Insider trades

Andrew Paul Mazar, COO of Actuate Therapeutics ACTU, has filed 0 purchases and 2 sales on the open market. The latest trade was on 04/01.

Andrew Paul Mazar

COO
First filing
25/04/02
Trades
5 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
04/01

Trading activity

Transactions

Trade type
Open-market sale25/09/2425/09/26550,229 sh$63.61$35,000,066.69−66.9%
Open-market sale25/04/0225/04/0433,334 sh$35.00$1,166,690−3.9%